Thrilled to have our clinical team’s publications presented at #ESTRO, alongside our research partners at the Cleveland Clinic.
#protontherapy#LIGHT#ESTRO
Don’t forget to register! Join our leading experts at the 11th HITRIplus Seminar on 20 April to learn more about #LIGHT and discover the latest breakthroughs in linear accelerators. https://t.co/EOzL4boj4A
#protontherapy#LIGHT#HITRIplus
On this #WorldHealthDay we wish good health to all and express our hopes to one day achieve a cancer free world. Until that day, #protontherapy offers improved outcomes for cancer patients, and our mission is to democratise access to this treatment. https://t.co/l42Nqd4nYu #LIGHT
Oesophageal cancers were previously difficult to treat, close to critical organs at risk of damage from treatment. #Protontherapy has changed the outlook for these patients, and #LIGHT is the future of #protontherapy. https://t.co/l42Nqd4nYu
#LIGHT#OesophagealCancer
Register now! Join our leading experts at the 11th HITRIplus Seminar on 20 April to learn about #LIGHT and discover the latest breakthroughs in linear accelerators. Anna Kolano Steve Myers Alberto Degiovanni
https://t.co/EOzL4bnLf2
#protontherapy#LIGHT#HITRIplus
Louise Harley-Smeur, Head of IP at Advanced Oncotherapy, celebrated the inauguration of Rotterdam Square earlier this week. We are thrilled about the future opening of this med-tech hub.
#protontherapy#LIGHT#RotterdamSquare
Thank you @heidi_news for this wonderful spotlight on our LIGHT system’s technology! Read the full article here https://t.co/0CwIcrqxzL
#protontherapy#LIGHT#CERN#ADAM
Today we celebrate all of the pioneering women who paved the way for today’s success in treating cancer, and the accomplishments of the talented women at Advanced Oncotherapy taking us one step closer to bringing our LIGHT system to market and democratising proton therapy.
A recent treatment planning study by our clinical team in partnership with the Cleveland Clinic has shown superior treatment outcomes with the LIGHT system for breast cancer patients.
https://t.co/40d2ru0UCA
#protontherapy#cancercure#TripleNegativeBreastCancerDay
In a month that acknowledges cancer and childhood cancer, we are proud of what we have accomplished to help in the fight against cancer. Achieving 230 MeV was a major milestone in bringing LIGHT closer to treating patients and democratize proton therapy.
https://t.co/Ttk2maeEZs
Following International Childhood Cancer Day, we’d like to highlight that proton therapy is a good treatment option for paediatric cancers, sparing more healthy growing tissue. To learn more about proton therapy and the advantages of LIGHT system, visit https://t.co/lK0zyOJMVJ
A recent article from our partners at @CERN highlights the importance of their technology contributions to our LIGHT system, which is now capable of treating a tumour at any depth in any patient. Read more here. https://t.co/eh2uPVNudW
#CERN#protontherapy#cancercure#230mev
February 4th is @WorldCancerDay. One third of countries worldwide do not have radiotherapy facilities, and even less have access to proton therapy, mainly due to cost. Our mission is to democratise proton therapy and help defeat cancer. Read more here https://t.co/l42Nqd4nYu
Thanks to the BBC for highlighting the benefits of proton therapy in breast tumours.
https://t.co/ia29D2dYtf
Jonathan’s Breast Study Video link:
https://t.co/40d2ru1ss8
January is cervical cancer awareness month in the US, with this week designated cervical cancer prevention week in the UK. Clinical trials are underway to assess the use of proton therapy for certain cases of cervical cancer. To learn more about PT, visit https://t.co/lK0zyOJMVJ
LIGHT is the first linear accelerator capable of accelerating a proton beam up to maximum system energy of 230 MeV. Read our latest report from Hardman & Co to understand more.
https://t.co/Bo8On2HOvy
#protontherapy#cancercure#breakthrough#230mev
Advanced Oncotherapy plc are pleased to share our latest operational update for key highlights achieved in 2022, and key deliverables for the year ahead.
https://t.co/PvswkbrUQu